WO2022088305A1 - 一种中间体4,4-二甲基异恶唑-3-酮的纯化方法 - Google Patents
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法 Download PDFInfo
- Publication number
- WO2022088305A1 WO2022088305A1 PCT/CN2020/129936 CN2020129936W WO2022088305A1 WO 2022088305 A1 WO2022088305 A1 WO 2022088305A1 CN 2020129936 W CN2020129936 W CN 2020129936W WO 2022088305 A1 WO2022088305 A1 WO 2022088305A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dimethylisoxazol
- chloro
- solution
- catalyst
- reaction
- Prior art date
Links
- UUXRXRHXOZHHJV-UHFFFAOYSA-N 4,4-dimethyl-1,2-oxazolidin-3-one Chemical compound CC1(C)CONC1=O UUXRXRHXOZHHJV-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000000746 purification Methods 0.000 title claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000010992 reflux Methods 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 9
- 238000007670 refining Methods 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 62
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 42
- OHXAOPZTJOUYKM-UHFFFAOYSA-N 3-Chloro-2-methylpropene Chemical group CC(=C)CCl OHXAOPZTJOUYKM-UHFFFAOYSA-N 0.000 claims description 35
- YBJGQSNSAWZZHL-UHFFFAOYSA-N 3-chloro-2,2-dimethylpropanoic acid Chemical compound ClCC(C)(C)C(O)=O YBJGQSNSAWZZHL-UHFFFAOYSA-N 0.000 claims description 33
- 239000003054 catalyst Substances 0.000 claims description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 26
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 238000007334 copolymerization reaction Methods 0.000 claims description 13
- 239000003513 alkali Substances 0.000 claims description 9
- MNIBWIBHURDIKQ-UHFFFAOYSA-N N-(3-chloro-2,2-dimethylpropyl)hydroxylamine Chemical compound ClCC(CNO)(C)C MNIBWIBHURDIKQ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 7
- 150000003983 crown ethers Chemical class 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- XDIAMRVROCPPBK-UHFFFAOYSA-N 2,2-dimethylpropan-1-amine Chemical compound CC(C)(C)CN XDIAMRVROCPPBK-UHFFFAOYSA-N 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- KWISWUFGPUHDRY-UHFFFAOYSA-N 1-Chloro-2-methylpropene Chemical compound CC(C)=CCl KWISWUFGPUHDRY-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000005499 Clomazone Substances 0.000 abstract description 7
- KIEDNEWSYUYDSN-UHFFFAOYSA-N clomazone Chemical compound O=C1C(C)(C)CON1CC1=CC=CC=C1Cl KIEDNEWSYUYDSN-UHFFFAOYSA-N 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FUOSTELFLYZQCW-UHFFFAOYSA-N 1,2-oxazol-3-one Chemical compound OC=1C=CON=1 FUOSTELFLYZQCW-UHFFFAOYSA-N 0.000 description 5
- 239000012670 alkaline solution Substances 0.000 description 5
- 238000006482 condensation reaction Methods 0.000 description 5
- 238000009834 vaporization Methods 0.000 description 5
- 230000008016 vaporization Effects 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- MQZNDDUMJVSIMH-UHFFFAOYSA-N 3-chloro-2,2-dimethylpropanoyl chloride Chemical compound ClCC(C)(C)C(Cl)=O MQZNDDUMJVSIMH-UHFFFAOYSA-N 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- CTHYVSYAUPROCF-UHFFFAOYSA-N CC(C)(C)CN(O)Cl Chemical compound CC(C)(C)CN(O)Cl CTHYVSYAUPROCF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- NTSVXMGHAIZLPZ-UHFFFAOYSA-N n-(2,2-dimethylpropyl)hydroxylamine Chemical compound CC(C)(C)CNO NTSVXMGHAIZLPZ-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- 150000003990 18-crown-6 derivatives Chemical group 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- LOBXXWMXAMOBAH-UHFFFAOYSA-N 3-chloro-n-hydroxy-2,2-dimethylpropanamide Chemical compound ClCC(C)(C)C(=O)NO LOBXXWMXAMOBAH-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
Definitions
- the invention relates to a purification method of an intermediate 4,4-dimethylisoxazol-3-one.
- Clomazone is a new type of high-efficiency pesticide introduced from abroad. Its application is more and more extensive, and it has the advantages of wide herbicidal spectrum, good herbicidal effect, long application time, good miscibility, and environmental safety.
- the synthetic routes of clomazone mainly include the o-chlorobenzaldehyde method and the chloropivaloyl chloride method.
- the chloropivaloyl chloride method is widely used in industrial production.
- 4,4-dimethylisoxazole-3- Ketone is a reaction intermediate for the preparation of clomazone by the chloropivaloyl chloride method, and its preparation is particularly critical.
- the purpose of the present invention is to provide a purification method of an intermediate 4,4-dimethylisoxazole-3-one, which solves the problem of the original 4,4-dimethylisoxazole-
- the product purity is not high and it is difficult to refine, and the reagents used are water, alcohol, etc., which are relatively clean and environmentally friendly.
- the purification method of an intermediate 4,4-dimethylisoxazol-3-one according to the present invention comprises the following steps:
- the reaction solution contains 4,4-dimethylisoxazol-3-one, 3-chloro-2-methylpropene, sodium chloride and sodium hydroxide etc.; in order to remove other water-soluble impurities such as free alkali and hydroxylamine hydrochloride, the pH of the reaction solution in step (1) is 8.0-8.5.
- step (1.2) is absolute ethanol.
- the purpose of step (1.2) is to carry out a trace amount of unreacted 3-chloro-2-methylpropene with the alcohol to remove the remaining 3-chloro-2-methylpropene.
- the acid in the step (1.3) is hydrochloric acid or sulfuric acid, which is acidified to neutralize the free base, the pH value after acidification is 6.5-7.0, and the product is precipitated in solid form.
- the catalyst I is BF 3 ⁇ (H 2 O) x or H 2 SO 4 ⁇ (H 2 O) x or H 3 PO 4 ⁇ (H 2 O) x or a mixture thereof; the The amount of catalyst I used is 3-5% of the molar amount of 3-chloro-2-methylpropene.
- BF 3 ⁇ (H 2 O) x selects BF 3 ⁇ (H 2 O) 2 ;
- H 2 SO 4 ⁇ (H 2 O) x selects H 2 SO 4 ⁇ H 2 O or H 2 SO 4 ⁇ (H 2 O) ) 2 or H 2 SO 4 ⁇ (H 2 O) 4 ;
- H 3 PO 4 ⁇ (H 2 O) x selects phosphoric acid hemihydrate.
- step (2.1) the copolymerization reaction pressure is maintained at 10-100 MPa; the copolymerization reaction temperature is 120-150° C.; and the copolymerization reaction time is 3-5 hours.
- the mass fraction of the alkali in the aqueous solution of the alkali is 30-40%, and the alkali is sodium hydroxide or potassium hydroxide; the pH of the solution II is 7.0-7.5; the catalyst described in the step (2.2) II is selected from KI+polyethylene glycol or KI+crown ether or KI+triethylene glycol; the dosage of the catalyst II is 5-8% of the molar amount of 3-chloro-2-methylpropene.
- the crown ethers can be 15-crown-5 and 18-crown-6.
- step (2.3) the reaction temperature is 35-45° C., and the reaction time is 5-8 h; the pH of the alkaline condition described in step (2.3) is maintained at 8.5-9.5.
- the invention has simple purification process and strong post-treatment operability, and solves the problems of low product purity and difficulty in refining in the original 4,4-dimethylisoxazol-3-one preparation technology and affecting the purity of the subsequent product clomazone.
- the key technical problem is in line with the concept of green economic circulation. After the purification of the present invention, the purity of the subsequent product clomazone is greatly improved.
- the reagents used in the present invention are water, alcohol, etc., which are relatively clean and environmentally friendly.
- a purification method of intermediate 4,4-dimethylisoxazol-3-one comprising the steps:
- the consumption of the catalyst I is 3% of the molar amount of 3-chloro-2-methylpropene.
- the amount of the catalyst II used is 8% of the molar amount of 3-chloro-2-methylpropene.
- a purification method of intermediate 4,4-dimethylisoxazol-3-one comprising the steps:
- the consumption of the catalyst I is 5% of the molar amount of 3-chloro-2-methylpropene.
- the consumption of the catalyst II is 5% of the molar amount of 3-chloro-2-methylpropene
- a purification method of intermediate 4,4-dimethylisoxazol-3-one comprising the steps:
- the consumption of the catalyst I is 4% of the molar amount of 3-chloro-2-methylpropene.
- the amount of the catalyst II used is 6% of the molar amount of 3-chloro-2-methylpropene.
- a purification method of intermediate 4,4-dimethylisoxazol-3-one comprising the steps:
- the consumption of the catalyst I is 5% of the molar amount of 3-chloro-2-methylpropene.
- the amount of the catalyst II used is 7% of the molar amount of 3-chloro-2-methylpropene.
- a purification method of intermediate 4,4-dimethylisoxazol-3-one comprising the steps:
- the consumption of the catalyst I is 3% of the molar amount of 3-chloro-2-methylpropene.
- the amount of the catalyst II used is 8% of the molar amount of 3-chloro-2-methylpropene.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,该纯化方法将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在7.5~9.0,然后用醇溶解,蒸馏,回流,酸化,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,纯度可达99.5%以上。上述纯化工艺简单,后处理可操作性强,解决了原有4,4-二甲基异恶唑-3-酮制备技术中产品纯度不高、难于精制,影响后续产品广灭灵纯度的关键技术问题,符合绿色经济循环理念。
Description
本发明涉及一种中间体4,4-二甲基异恶唑-3-酮的纯化方法。
广灭灵为我国从国外引进的新型高效农药,其应用越来越广泛,具有杀草谱宽,除草效果好,施药时间长,可混性好,对环境安全等优点。目前。广灭灵的合成路线主要有邻氯苯甲醛法和氯代特戊酰氯法两种,氯代特戊酰氯法在工业生产上被广泛采用,4,4-二甲基异恶唑-3-酮作为氯代特戊酰氯法制备广灭灵的反应中间体,其制备尤为关键。
4,4-二甲基异恶唑-3-酮传统制备工艺是将N-羟基-3-氯-2,2-二甲基丙酰胺溶解在甲醇中,滴加氢氧化钠的甲醇溶液,加水稀释后,用二氯甲烷萃取,蒸去二氯甲烷得产品,其产品纯度一直不高,这直接影响了后续农药广灭灵的产品质量,因此4,4-二甲基异恶唑-3-酮的纯化方法的改进尤为迫切。
发明内容
针对现有技术的不足,本发明的目的是提供一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,解决了原有4,4-二甲基异恶唑-3-酮制备技术中产品纯度不高、难于精制的难题,并且所用的试剂为水、醇等,相对清洁环保。
本发明所述的一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在7.5~9.0并停止;
(1.2)将油相用醇溶解,蒸馏1-2min,回流1-2h,得溶液I;
(1.3)回流完毕向溶液I中加入酸酸化,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮。
4,4-二甲基异恶唑-3-酮反应液中有4,4-二甲基异恶唑-3-酮、3-氯-2-甲基丙烯、氯化钠、氢氧化钠等;水洗反应液为去除游离碱、盐酸羟胺等其他水溶性杂质,步骤(1)中pH为8.0~8.5。
步骤(1.2)中所述醇为无水乙醇。步骤(1.2)的目的是微量未反应的3-氯-2-甲基丙烯随醇被带出,除去剩余3-氯-2-甲基丙烯。
步骤(1.3)中所述酸为盐酸或硫酸,酸化中和游离碱,酸化后pH值为6.5~7.0,产品以固体形式析出。
本发明所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)在催化剂I存在下,一氧化碳与3-氯-2-甲基丙烯发生共聚反应,反应完毕,一氧化碳停止供气,降温,经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸;
(2.2)将盐酸羟胺溶解于碱的水溶液中,加入催化剂II,同时将3-氯特戊酸在50~70℃ 加入上述溶液中,保温1-2h,得到中间体3-氯-N-羟基-2,2-二甲基丙胺的水溶液;以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.1~1.3,具体以液相色谱定量3-氯特戊酸,滴定法定量盐酸羟胺。
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺水溶液在碱性条件下关环得到4,4-二甲基异恶唑-3-酮反应液;
步骤(2.1)中,所述催化剂I为BF
3·(H
2O)
x或H
2SO
4·(H
2O)
x或H
3PO
4·(H
2O)
x或其混合物;所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的3~5%。BF
3·(H
2O)
x选用BF
3·(H
2O)
2;H
2SO
4·(H
2O)
x选用H
2SO
4·H
2O或H
2SO
4·(H
2O)
2或H
2SO
4·(H
2O)
4;H
3PO
4·(H
2O)
x选用磷酸半水合物。
步骤(2.1)中,所述共聚反应压力维持在10~100MPa;共聚反应温度120~150℃;共聚反应时间为3~5小时。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:1.5-2.0:1.1-1.2。
步骤(2.2)中碱的水溶液中碱的质量分数为30~40%,所述的碱为氢氧化钠或氢氧化钾;溶液II的pH为7.0~7.5;步骤(2.2)中所述的催化剂II选自KI+聚乙二醇或KI+冠醚或KI+三甘醇;所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的5-8%。所述的冠醚可以采用15-冠-5、18-冠-6。
步骤(2.3)中反应温度为35~45℃,反应时间5-8h;步骤(2.3)中所述碱性条件的pH保持在8.5-9.5。
本发明纯化工艺简单,后处理可操作性强,解决了原有4,4-二甲基异恶唑-3-酮制备技术中产品纯度不高、难于精制,影响后续产品广灭灵纯度的关键技术问题,符合绿色经济循环理念,经本发明纯化后,后续产品广灭灵纯度大大提高,另外,本发明所用的试剂为水、醇等,相对清洁环保。
为了更好的理解本发明的技术方案,以下通过实施例形式的具体实施方式,对本发明的上述内容做进一步的详细说明,但不应将此理解为本发明是对上述内容的限定。
实施例1
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在7.5并停止;
(1.2)将油相用无水乙醇250g溶解,蒸馏1min,回流1h,得溶液I;
(1.3)回流完毕向溶液I中加入浓盐酸酸化pH值为6.8,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,收率96.5%,产品纯度99.8%。
所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)反应器中加入催化剂I BF
3·(H
2O)
2,注入一氧化碳气源,高压50MPa下,温 度升至130℃,分批次加入3-氯-2-甲基丙烯181g,3-氯-2-甲基丙烯与一氧化碳气体在反应釜内发生汽化共聚反应,保温反应5小时,得到3-氯特戊酸反应液,停止一氧化碳气源,并降温至75℃。所述3-氯特戊酸反应液经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸。
(2.2)盐酸羟胺溶解在40%的氢氧化钠水溶液中,加入催化剂II KI+聚乙二醇,保持pH为7.0,将3-氯特戊酸加入至上述碱溶液中,70℃缩合反应得到3-氯-N-羟基-2,2-二甲基丙胺的水溶液。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:1.5:1.2;
以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.3。
所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的3%。
所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的8%。
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺的水溶液,继续在氢氧化钠碱性条件下保持pH为8.5,40℃反应6小时,得到4,4-二甲基异恶唑-3-酮反应液。
实施例2
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在8.0并停止;
(1.2)将油相用无水乙醇250g溶解,蒸馏2min,回流1h,得溶液I;
(1.3)回流完毕向溶液I中加入浓盐酸酸化pH值为6.8,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,收率92.3%,产品纯度99.6%。
所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)反应器中加入催化剂I H
2SO
4·(H
2O)
2,注入一氧化碳气源,高压10MPa下,温度升至130℃,分批次加入3-氯-2-甲基丙烯181g,3-氯-2-甲基丙烯与一氧化碳气体在反应釜内发生汽化共聚反应,保温反应5小时,得到3-氯特戊酸反应液,停止一氧化碳气源,并降温至75℃。所述3-氯特戊酸反应液经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸。
(2.2)盐酸羟胺溶解在30%的氢氧化钠水溶液中,加入催化剂II KI+冠醚,保持pH为7.5,将3-氯特戊酸加入至上述碱溶液中,60℃缩合反应得到3-氯-N-羟基-2,2-二甲基丙胺的水溶液。所述冠醚为18-冠-6。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:2.0:1.1。
以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.1。
所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的5%。
所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的5%
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺的水溶液,继续在氢氧化钠碱性条件下保持pH=8.5,45℃反应8小时得到4,4-二甲基异恶唑-3-酮反应液。
实施例3
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在8.0并停止;
(1.2)将油相用无水乙醇250g溶解,蒸馏2min,回流2h,得溶液I;
(1.3)回流完毕向溶液I中加入浓盐酸酸化pH值为6.5,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,收率94.7%,产品纯度99.7%。
所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)反应器中加入催化剂I H
2SO
4·(H
2O)
4,注入一氧化碳气源,高压50MPa下,温度升至135℃,分批次加入3-氯-2-甲基丙烯181g,3-氯-2-甲基丙烯与一氧化碳气体在反应釜内发生汽化共聚反应,保温反应3小时,得到3-氯特戊酸反应液,停止一氧化碳气源,并降温至75℃。所述3-氯特戊酸反应液经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸。
(2.2)盐酸羟胺溶解在40%的氢氧化钠水溶液中,加入催化剂II KI+三甘醇,保持pH为7.5,将3-氯特戊酸加入至上述碱溶液中,50℃缩合反应得到3-氯-N-羟基-2,2-二甲基丙胺的水溶液。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:1.8:1.2。
以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.2。
所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的4%。
所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的6%。
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺的水溶液,继续在氢氧化钠碱性条件下保持pH=9.0,35℃反应5小时,得到4,4-二甲基异恶唑-3-酮反应液。
实施例4
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在8.5并停止;
(1.2)将油相用无水乙醇250g溶解,蒸馏1min,回流1h,得溶液I;
(1.3)回流完毕向溶液I中加入浓盐酸酸化pH值为6.8,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,收率96.3%,产品纯度99.7%。
所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)反应器中加入催化剂I H
2SO
4·H
2O,注入一氧化碳气源,高压100MPa下,温度升至120℃,分批次加入3-氯-2-甲基丙烯181g,3-氯-2-甲基丙烯与一氧化碳气体在反应釜内发生汽化共聚反应,保温反应5小时,得到3-氯特戊酸反应液,停止一氧化碳气源,并降温至75℃。所述3-氯特戊酸反应液经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸。
(2.2)盐酸羟胺溶解在30%的氢氧化钾水溶液中,加入催化剂II KI+三甘醇,保持pH 为7.5,将3-氯特戊酸加入至上述碱溶液中,70℃缩合反应得到3-氯-N-羟基-2,2-二甲基丙胺的水溶液。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:2.0:1.1。
以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.3。
所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的5%。
所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的7%。
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺的水溶液,继续在氢氧化钾碱性条件下保持pH=9.0,45℃反应5小时,得到4,4-二甲基异恶唑-3-酮反应液。
实施例5
一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,包括如下步骤:
(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在8.5并停止;
(1.2)将油相用无水乙醇250g溶解,蒸馏2min,回流1h,得溶液I;
(1.3)回流完毕向溶液I中加入浓盐酸酸化pH值为6.8,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮,收率95.2%,产品纯度99.6%。
所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:
(2.1)反应器中加入催化剂I磷酸半水合物,注入一氧化碳气源,高压80MPa下,温度升至150℃,分批次加入3-氯-2-甲基丙烯181g,3-氯-2-甲基丙烯与一氧化碳气体在反应釜内发生汽化共聚反应,保温反应4小时,得到3-氯特戊酸反应液,停止一氧化碳气源,并降温至75℃。所述3-氯特戊酸反应液经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸。
(2.2)盐酸羟胺溶解在40%的氢氧化钾水溶液中,加入催化剂II KI+冠醚,保持pH为7.0,将3-氯特戊酸加入至上述碱溶液中,60℃缩合反应得到3-氯-N-羟基-2,2-二甲基丙胺的水溶液。
以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:1.5:1.2。
以摩尔比计,3-氯特戊酸:盐酸羟胺=1:1.1。
所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的3%。
所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的8%。
(2.3)将3-氯-N-羟基-2,2-二甲基丙胺的水溶液,继续在氢氧化钾碱性条件下保持pH=9.0,40℃反应5小时,得到4,4-二甲基异恶唑-3-酮反应液。
Claims (9)
- 一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,其特征在于,包括如下步骤:(1.1)将4,4-二甲基异恶唑-3-酮反应液用纯水洗涤至反应液油相pH在7.5~9.0并停止;(1.2)将油相用醇溶解,蒸馏1-2min,回流1-2h,得溶液I;(1.3)回流完毕向溶液I中加入酸酸化,析晶,过滤,得到固体4,4-二甲基异恶唑-3-酮。
- 根据权利要求1所述的一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,其特征在于,步骤(1.1)中pH为8.0~8.5。
- 根据权利要求1所述的一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,其特征在于,步骤(1.2)中所述醇为无水乙醇。
- 根据权利要求1所述的一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,其特征在于,步骤(1.3)中所述酸为盐酸或硫酸,酸化后pH值为6.5-7.0。
- 根据权利要求1所述的一种中间体4,4-二甲基异恶唑-3-酮的纯化方法,其特征在于,所述4,4-二甲基异恶唑-3-酮反应液的获得过程为:(2.1)在催化剂I存在下,一氧化碳与3-氯-2-甲基丙烯发生共聚反应,反应完毕,一氧化碳停止供气,降温,经水蒸气蒸馏,乙醚萃取精制得到3-氯特戊酸;(2.2)将盐酸羟胺溶解于碱的水溶液中,加入催化剂II,同时将3-氯特戊酸在50~70℃加入上述溶液中,保温1-2h,得到中间体3-氯-N-羟基-2,2-二甲基丙胺的水溶液;(2.3)将3-氯-N-羟基-2,2-二甲基丙胺水溶液在碱性条件下关环得到4,4-二甲基异恶唑-3-酮反应液;以摩尔比计,3-氯-2-甲基丙烯:一氧化碳:盐酸羟胺:=1:1.5-2.0:1.1-1.2;所述催化剂I为BF 3·(H 2O) x或H 2SO 4·(H 2O) x或H 3PO 4·(H 2O) x或其混合物;所述催化剂I的用量为3-氯-2-甲基丙烯摩尔量的3~5%;步骤(2.2)中所述的催化剂II选自KI+聚乙二醇或KI+冠醚或KI+三甘醇;所述催化剂II的用量为3-氯-2-甲基丙烯摩尔量的5-8%。
- 根据权利要求5所述的一种中间体4,4-二甲基异恶唑-3-酮的的纯化方法,其特征在于,步骤(2.1)中,所述共聚反应压力维持在10~100MPa;共聚反应温度120~150℃;共聚反应时间为3~5小时。
- 根据权利要求5所述的一种中间体4,4-二甲基异恶唑-3-酮的的纯化方法,其特征在于:步骤(2.2)中碱的水溶液中碱的质量分数为30~40%,所述的碱为氢氧化钠或氢氧化钾;加入加入催化剂II后体系的pH为7.0~7.5。
- 根据权利要求5所述的一种中间体4,4-二甲基异恶唑-3-酮的的纯化方法,其特征在于:步骤(2.3)中反应温度为35~45℃,反应时间5-8h。
- 根据权利要求5所述的一种中间体4,4-二甲基异恶唑-3-酮的的纯化方法,其特征在于:步骤(2.3)中所述碱性条件的pH保持在8.5-9.5。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011171671.6A CN112159362B (zh) | 2020-10-28 | 2020-10-28 | 一种中间体4,4-二甲基异恶唑-3-酮的纯化方法 |
CN202011171671.6 | 2020-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022088305A1 true WO2022088305A1 (zh) | 2022-05-05 |
Family
ID=73866271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/129936 WO2022088305A1 (zh) | 2020-10-28 | 2020-11-19 | 一种中间体4,4-二甲基异恶唑-3-酮的纯化方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112159362B (zh) |
WO (1) | WO2022088305A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112174906B (zh) * | 2020-10-28 | 2023-07-04 | 山东兴强化工产业技术研究院有限公司 | 一种中间体4,4-二甲基异恶唑-3-酮的制备方法 |
CN113620896A (zh) * | 2021-08-31 | 2021-11-09 | 青岛科技大学 | 2-(2-氯苯基)甲基-4,4-二甲基-3-异恶唑酮的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066665A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Co. | Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors |
CN1775765A (zh) * | 2005-11-29 | 2006-05-24 | 江苏长青农化股份有限公司 | 一种4,4-二甲基异噁唑-3-酮的合成方法 |
WO2015000353A1 (en) * | 2013-07-03 | 2015-01-08 | Rotam Agrochem International Co. Ltd | Process for preparing clomazone, novel form and use of the same |
CN106749072A (zh) * | 2016-11-12 | 2017-05-31 | 江苏长青生物科技有限公司 | 异恶草酮的制备方法 |
CN110546144A (zh) * | 2017-04-10 | 2019-12-06 | 菲尼克斯-Fxr股份有限公司 | 肝x受体(lxr)调节剂 |
-
2020
- 2020-10-28 CN CN202011171671.6A patent/CN112159362B/zh active Active
- 2020-11-19 WO PCT/CN2020/129936 patent/WO2022088305A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066665A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Co. | Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors |
CN1775765A (zh) * | 2005-11-29 | 2006-05-24 | 江苏长青农化股份有限公司 | 一种4,4-二甲基异噁唑-3-酮的合成方法 |
WO2015000353A1 (en) * | 2013-07-03 | 2015-01-08 | Rotam Agrochem International Co. Ltd | Process for preparing clomazone, novel form and use of the same |
CN106749072A (zh) * | 2016-11-12 | 2017-05-31 | 江苏长青生物科技有限公司 | 异恶草酮的制备方法 |
CN110546144A (zh) * | 2017-04-10 | 2019-12-06 | 菲尼克斯-Fxr股份有限公司 | 肝x受体(lxr)调节剂 |
Non-Patent Citations (1)
Title |
---|
LI, CHENGFAN ET AL.: "The improvement method for synthesize of 2-(2-chlorophenylmethyl)-4, 4-dimethyl-3- isoxazolidinone", JOURNAL OF YANBIAN UNIVERSITY ( NATURAL SCIENCE EDITION, vol. 30, no. 4, 31 December 2004 (2004-12-31), pages 270 - 273, XP009192777 * |
Also Published As
Publication number | Publication date |
---|---|
CN112159362B (zh) | 2023-01-13 |
CN112159362A (zh) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022088305A1 (zh) | 一种中间体4,4-二甲基异恶唑-3-酮的纯化方法 | |
RU2540076C2 (ru) | Способ получения производных 1-(2-галогенобифенил-4-ил)-циклопропанкарбоновой кислоты | |
WO2022088306A1 (zh) | 一种中间体4,4-二甲基异恶唑-3-酮的制备方法 | |
CN108440409B (zh) | 一种瑞巴匹特的绿色高效制备方法 | |
CN112047883A (zh) | 顺苯磺酸阿曲库铵的制备方法 | |
KR101002061B1 (ko) | 4-아미노메틸벤조산 제조방법 | |
CN109867604A (zh) | 一种对氨基苯甲酰胺的环保生产工艺 | |
WO2017211129A1 (zh) | 麻黄碱或伪麻黄碱及麻黄碱或伪麻黄碱中间体的制备方法 | |
CN107032952B (zh) | 一种2-甲基烯丙醇的制备工艺 | |
JP2002179622A (ja) | 4−アセトキシスチレンの製造方法 | |
US2553055A (en) | Synthesis of 5-(sec.-butyl) hydantion | |
CN111196770B (zh) | 一种溴芬酸钠的简便制备方法 | |
CN113354529B (zh) | 一种利用bdo装置副产2-羟甲基丙醛合成2,2-二羟甲基丙酸方法 | |
CN115819251B (zh) | 一种(1r)-1-[3-(二氟甲基)-2-氟苯基]乙胺的制备方法 | |
CN106957235A (zh) | 一种他莫昔芬的制备方法 | |
CN111423319B (zh) | 一种洛索洛芬的制备方法 | |
CN102659162B (zh) | 一种利用四丁基溴化铵结晶母液制备溴化钙的方法 | |
CN101844989A (zh) | 一种氯苯达诺及其盐酸盐的制备方法 | |
WO2022088304A1 (zh) | 一种3-氯特戊酸的制备方法 | |
CN108863792B (zh) | 一种异香茅烯的综合利用方法 | |
CN104649994A (zh) | 一种低成本的4-甲基-5-烷氧基噁唑的环保制备方法 | |
US2165445A (en) | Preparation of phenyl methyl pyrazyl phenyl methyl pyrazolone | |
CN117088842A (zh) | 一种2,4-丁烷磺酸内酯的合成方法 | |
US2967874A (en) | Process for increasing the chain length of levulinic acid | |
WO2021224934A1 (en) | Process for preparation of tert-butylamine and propionic acid salts from n-tertiary butyl acrylamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20959465 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20959465 Country of ref document: EP Kind code of ref document: A1 |